-
ACTG LEADERSHIP STATEMENT ON DEREK CHAUVIN VERDICT
Apr 22, 2021
-
ACTG ADDS FIRST POLYCLONAL ANTIBODY TO ACTIV-2 OUTPATIENT TREATMENT STUDY FOR COVID-19
Apr 21, 2021
-
Mar 04, 2021
-
ACTG TO PRESENT 24 NEW STUDIES AT CROI 2021
Mar 03, 2021
-
ACTG ADDS FOUR PROMISING NEW THERAPIES TO ACTIV-2 OUTPATIENT TREATMENT STUDY
Feb 12, 2021
-
Feb 02, 2021
-
Feb 02, 2021
-
Feb 02, 2021
-
Feb 02, 2021
-
Feb 02, 2021
-
Feb 02, 2021
-
Feb 02, 2021
Press Releases & Announcements